Floros, Lefteris
Kuessner, Daniel
Posthumus, Jan
Bagshaw, Emma
Sjölin, Jan
Funding for this research was provided by:
Basilea Pharmaceutica International Ltd.
Article History
Received: 23 April 2018
Accepted: 7 January 2019
First Online: 11 February 2019
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: DK and JP are employees of Basilea Pharmaceutica International Ltd., Switzerland and all hold stock options with Basilea.EB and LF report personal fees from Covance, who were commissioned by Basilea to carry out study analysis.JS has received personal fees from Unimedic for expert testimony, and from Pfizer and Gilead for lectures, all outside the scope of the current work.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.